2007
DOI: 10.1128/jcm.02029-06
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
261
1
17

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 354 publications
(294 citation statements)
references
References 28 publications
2
261
1
17
Order By: Relevance
“…14 , 15 While these techniques have increased sensitivity, can detect active infections, and can be used for CL patients; they also require sufficient technical skill, equipment, continual electricity, and are considerably more expensive than the serological tests. 16 Therefore, many of these tests are not suitable for diagnosis in endemic regions, except in wellequipped laboratories. Isothermal amplification techniques such as nucleic acid sequence-based amplification (NASBA) for leishmaniasis have also been developed 17 ; however, the post-amplification analysis with oligo-chromatography makes this technique time-consuming and contamination prone.…”
Section: Introductionmentioning
confidence: 99%
“…14 , 15 While these techniques have increased sensitivity, can detect active infections, and can be used for CL patients; they also require sufficient technical skill, equipment, continual electricity, and are considerably more expensive than the serological tests. 16 Therefore, many of these tests are not suitable for diagnosis in endemic regions, except in wellequipped laboratories. Isothermal amplification techniques such as nucleic acid sequence-based amplification (NASBA) for leishmaniasis have also been developed 17 ; however, the post-amplification analysis with oligo-chromatography makes this technique time-consuming and contamination prone.…”
Section: Introductionmentioning
confidence: 99%
“…Rapid and more efficient serological tests have been developed and validated as a tool to supplement the microscopic diagnosis. 6,7 Immunoserologic studies for VL in dogs, such as direct agglutination test (DAT), 8 indirect immunofluorescence assay (IFA), 4 enzyme-linked immunosorbent assay (ELISA), 6,7 polymerase chain reaction, 9 and immunochromatographic tests 6,7 (ICTs) were adapted from assays validated in humans, [10][11][12][13] with different levels of performance in canine VL. A recombinant fusion protein with tandem repeats of k39 kinesin regions and K26/HASPb1 when used in ELISA was found to detect high levels of antibody responses in infected patients.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] An estimated 1.5 to 2 million new cases of leishmaniasis occurs each year in the world, which in the visceral manifestation is often fatal if untreated. [5][6][7][8][9] Unfortunately non-availability of satisfactory chemotherapeutic agents and failure to develop an effective Synthesis, X-ray Crystal Structure and Theoretical Calculations J. Braz. Chem.…”
Section: Introductionmentioning
confidence: 99%